Skip to main content
Clinical Trials/NCT02117908
NCT02117908
Completed
Not Applicable

Application of CPAP to Reduce Complications and Improve Treatment of Radiofrequency Ablation of Lung Cancer Under Conscious Sedation. A Randomized Study

Sara Varea1 site in 1 country47 target enrollmentNovember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atelectasis
Sponsor
Sara Varea
Enrollment
47
Locations
1
Primary Endpoint
Number of Participants with Adverse Events as a Measure of Safety
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The project aims to study whether the application of a continuous positive airway pressure (CPAP) of 4 cm water vapor is a safe method in pulmonary radiofrequency intervention (PRF) lung cancer under conscious sedation compared with placebo. And, assess whether CPAP prevents atelectasis formation and consequently reduces the potential complications of PRF and improves procedural success

Registry
clinicaltrials.gov
Start Date
November 2014
End Date
February 21, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sara Varea
Responsible Party
Sponsor Investigator
Principal Investigator

Sara Varea

Clinical Research Manager

Fundacion Clinic per a la Recerca Biomédica

Eligibility Criteria

Inclusion Criteria

  • male and female aged 18 years and older
  • Patient with a scheduled intervention for ablation of pulmonary malignant tumor with radiofrequency .
  • Patient able to undergo tests and examinations required by the study.

Exclusion Criteria

  • Patients with CPAP intolerance test.
  • Patients with progressive disease in which local treatment is not applicable
  • Patients with intercurrent process (pleural effusion, pneumonia, ...).
  • Patient unable to understand the proceedings.
  • Pregnancy or breastfeeding.

Outcomes

Primary Outcomes

Number of Participants with Adverse Events as a Measure of Safety

Time Frame: thirty days

Patients with any of the following complications Pulmonary over-distention along intervention Pneumothorax along intervention Bronchial fistulas measures Computed tomography (CT)1, CT2 and CT3 Vomiting along intervention Decrease in MAP (mean arterial pressure) \> 20% measured in the intraoperative period Assay of each of the previous complications

Secondary Outcomes

  • Treatment success(Measurement time: CT3)
  • Prevention of atelectasis.(during surgery)
  • Decrease associated complications with PFR. Measurement times: intraoperative, PACU (post-anesthesic care unit), hospital discharge, day 15 and day 30.(thirty days)
  • Predictors factors of the occurrence of complications during PRA (pulmonary radiofrequency ablation).(thirty days)

Study Sites (1)

Loading locations...

Similar Trials